Name: Caris Life Sciences, Inc. (CAI) Balance Sheet
Creator: FinSpry

Caris Life Sciences Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Caris Life Sciences, Inc. (CAI) - Annual data in billions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Current Assets
Cash and Cash Equivalents	0.06	0.06	0.11
Short-Term Investments	0.00	0.07	0.30
Cash & Short-Term Investments	0.07	0.12	0.41
Accounts Receivable	0.08	0.05	0.04
Inventory	0.04	0.05	0.05
Other Current Assets	0.01	0.00	0.00
Total Current Assets	0.22	0.24	0.52
Non-Current Assets
Property, Plant & Equipment (Net)	0.10	0.15	0.14
Goodwill	0.02	0.02	0.02
Other Non-Current Assets	0.01	0.00	0.04
Total Non-Current Assets	0.13	0.17	0.20
Total Assets	0.34	0.41	0.72
Current Liabilities
Accounts Payable	0.03	0.03	0.03
Short-Term Debt	0.06	0.00	0.05
Current Portion of Long-Term Debt	0.06	0.00	0.05
Accrued Liabilities	0.03	0.03	0.03
Deferred Revenue	0.01	0.01	0.00
Other Current Liabilities	0.00	0.01	0.00
Total Current Liabilities	0.17	0.10	0.14
Non-Current Liabilities
Long-Term Debt	0.32	0.17	0.17
Other Non-Current Liabilities	0.10	0.13	0.11
Total Non-Current Liabilities	2.68	2.46	2.28
Total Liabilities	2.84	2.56	2.42
Stockholders' Equity
Common Stock	0.00	0.00	0.00
Retained Earnings	-2.47	-2.12	-1.68
Accumulated Other Comprehensive Income	0.00	0.00	0.00
Treasury Stock	0.00	0.00	0.00
Shares Outstanding	0.28	0.28	0.28
Total Stockholders' Equity	-2.50	-2.14	-1.70
Total Liabilities & Equity	0.34	0.41	0.72